Healthcare / BiotechnologyUpdated 2026-05-10 22:07 UTC

YDES stock hub

YD Bio Limited has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

YDESis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

373.4M

NASDAQ

Market data

Live price

Current market quote for this ticker.

Current price

YDES

In the news

Latest news · YDES

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/En/a

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-42.7

P25 -105.6P50 -46.5P75 -3.1

ROIC-42

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All YDES market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

179

Groups with data

Currency

USD

Showing 179 of 179 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0002011674
Company name	YD Bio Limited
Country	Taiwan
Country code	US
Cusip	G98301107
Enterprise value	$370.3M
Exchange	NASDAQ
Financial currency	USD
First seen	2026-05-09
Industry	Biotechnology
Isin	KYG983011076
Last refreshed	2026-05-10
Market cap	$373.4M
Market cap category	Small-Cap
Price	$5.31
Price currency	USD
Sector	Healthcare
Sic	8071
Symbol	YDES
Website	https://www.ydesgroup.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-0.38%
EV/Sales	725.54x
FCF yield	-0.51%
P/B ratio	1.16x
P/S ratio	731.64x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	-286.45%
EBITDA Margin	-265.93%
Gross margin	30.44%
Gross Profit	$155,356
Gross Profit Growth	1.25%
Gross Profit Growth Q	21.98%
Net Income	$-1.4M
Net Income Growth Years	0%
Pretax Margin	-271.67%
Profit Margin	-276.58%
ROA	-25.43
ROCE	-22.15
ROE	-42.69
ROIC	-42.01

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	-55.02%
Cagr3y	-20.69%
Cagr5y	-11.91%
EPS Growth Years	0
Revenue Growth	45.76x
Revenue Growth Q	95.64x
Revenue Growth Years	2x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.14
Assets	$6.9M
Cash	$3.1M
Current Assets	$3.5M
Current Liabilities	$263,060
Debt	$22,265
Debt Equity	$0
Equity	$6.6M
Interest Coverage	-1,893.7
Liabilities	$273,980
Long Term Assets	$3.4M
Long Term Liabilities	$10,920
Net Cash	$3.1M
Net Cash By Market Cap	$0.83
Net Cash Growth	7,769.12%
Net Debt Equity	$-0.47
Tangible Book Value	$3.9M
Tangible Book Value Per Share	$2.71
WACC	3.94

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	13.18
Inventory Turnover	6.65
Net Working Capital	$89,105
Quick ratio	12.91
Working Capital	$3.2M
Working Capital Turnover	$0.32

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-4.01%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	-55%
200-day SMA	11.44
3Y total return	-50.11%
50-day SMA	6.53
50-day SMA vs 200-day SMA	50under200
5Y total return	-46.95%
All Time High	31
All Time High Change	-82.87%
All Time High Date	2025-04-15
All Time Low	4.73
All Time Low Change	12.26%
All Time Low Date	2026-05-04
ATR	0.45
Beta	-0.06
Beta1y	1.08
Beta2y	0.39
Ch YTD	-56.44
High	5.31
High52	25
High52 Date	2025-09-12
High52ch	-78.76%
Low	5.21
Low52	4.73
Low52 Date	2026-05-04
Low52ch	12.26%
Ma50ch	-18.71%
Price vs 200-day SMA	-53.58%
RSI	41.62
RSI Monthly	34
RSI Weekly	37.7
Sharpe ratio	0.5x
Sortino ratio	0.98
Total Return	-4.01%
Tr YTD	-56.44
Tr1m	-23.93%
Tr1w	10.63%
Tr3m	-52.93%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	$-1.5M
Operating margin	-286.5

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	15,600,837%
Float Percent	22.19%
Net Borrowing	181,874
Shares Insiders	77.38%
Shares Institutions	0.27%
Shares Out	70,319,824
Short Float	0.15%
Short Ratio	0.86
Short Shares	0.03

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$-1.9M
Average Volume	21,135.8x
Bv Per Share	4.57
CAPEX	$-74,914
Ch1m	-23.93
Ch1w	10.63
Ch1y	-55
Ch3m	-52.93
Ch3y	-50.11
Ch5y	-46.95
Ch6m	-40.93
Change	0.38%
Change From Open	1.92
Close	5.29
Days Gap	-1.51
Depreciation Amortization	104,735
Dollar Volume	14,937
Earnings Date	2026-04-30
Earnings Time	amc
EBIT	$-1.5M
EBITDA	$-1.4M
EPS	$-1.29
F Score	1
FCF	$-1.9M
FCF EV Yield	-0.52x
FCF Per Share	$-0.03
Financing CF	7,727,646
Fiscal Year End	December
Founded	2,013
Income Tax	$25,080
Investing CF	-2,900,670
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-04-30
Last Report Date	2024-12-31
Last Split Type	Never
Last10k Filing Date	2026-04-30
Ma150	10.45
Ma150ch	-49.2%
Ma20	5.29
Ma20ch	0.36%
Net CF	3,045,200
Next Earnings Date	2026-09-30
Open	5.21
Optionable	No
Position In Range	100
Post Close	5.31
Postmarket Change Percent	-1.22
Postmarket Price	$5.25
Ppne	88,077
Price Date	2026-05-08
Ptbv Ratio	95.49
Relative Volume	0.13x
Revenue	510,360x
Tax By Revenue	4.91x
Tr6m	-40.93%
Volume	2,813
Z Score	104.6

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does YDES pay a dividend?

Capital-return profile for this ticker.

Performance

YDES stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns YDES?

Insider, institutional, and short-interest positioning.

Institutional ownership

+0.3%

Float: +22.2% of shares outstanding

Insider ownership

+77.4%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

YDES momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

41.6

Neutral momentum band

Price vs 200-day MA

-53.6%

50/200-day relationship not available

Beta (5Y)

-0.06

Less volatile than the market

Sharpe ratio

0.50

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About YDES

Hub-level FAQ points readers to the deeper analysis pages.

What is the current YDES stock rating?

YD Bio Limited is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full YDES analysis?

The full report lives at /stocks/YDES/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for YDES?

The latest report frames YDES around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the YDES page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.